TAP2 and Burkitt lymphoma: However, overall TAP2 mRNA levels did not differ accordingly to the severity of histological lesions (BL, CIN 1, CIN 2, or CIN 3, N=100 patients; P=0.9783) (Figure 2D) or cell ploidy (N=93 patients; P=0.9032) (Figure 2E).